Yelin, 2016, The burden of musculoskeletal diseases in the United States, Semin Arthritis Rheum, 10.1016/j.semarthrit.2016.07.013
Andia, 2015, Platelet-rich Plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes, Clin Orthop Relat Res, 473, 1624, 10.1007/s11999-015-4179-z
Sugaya, 2003, Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases, Int Rev Cytol, 228, 1, 10.1016/S0074-7696(03)28001-3
Malanga, 2015, Regenerative treatment for orthopedic conditions, PM R, 10.1016/j.pmrj.2015.01.016
Sanchez, 2017, Platelet-rich plasma, an adjuvant biological therapy to assist peripheral nerve repair, Neural Regen Res, 12, 47, 10.4103/1673-5374.198973
Senzel, 2009, The platelet proteome, Curr Opin Hematol, 16, 329, 10.1097/MOH.0b013e32832e9dc6
Everts, 2006, Platelet rich plasma and platelet gel: a review, J Extra Corpor Technol, 38, 174, 10.1051/ject/200638174
Kovtun, 2016, The crucial role of neutrophil granulocytes in bone fracture healing, Eur Cell Mater, 32, 152, 10.22203/eCM.v032a10
Fitzpatrick, 2016, The effectiveness of platelet-rich plasma in the treatment of tendinopathy. a meta-analysis of randomized controlled clinical trials, Am J Sports Med, 10.1177/0363546516669322
Jorgensen, 2011, Mesenchymal stem cells in osteoarticular diseases, Regen Med, 6, 44, 10.2217/rme.11.80
Oh, 2015, The perivascular niche and self-renewal of stem cells, Front Physiol, 10.3389/fphys.2015.00367
Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143
Otero-Vinas, 2016, Mesenchymal stem cells in chronic wounds: the spectrum from basic to advanced therapy, Adv Wound Care (New Rochelle), 5, 149, 10.1089/wound.2015.0627
Mithoefer, 2009, Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis, Am J Sports Med, 37, 2053, 10.1177/0363546508328414
da Silva Meirelles, 2009, Mechanisms involved in the therapeutic properties of mesenchymal stem cells, Cytokine Growth Factor Rev, 20, 419, 10.1016/j.cytogfr.2009.10.002
Bashir, 2014, Mesenchymal stem cell therapies in the treatment of musculoskeletal diseases, PMR, 6, 61, 10.1016/j.pmrj.2013.05.007
Das, 2015, Monocyte and macrophage plasticity in tissue repair and regeneration, Am J Pathol, 185, 2596, 10.1016/j.ajpath.2015.06.001
Orozco, 2014, Treatment of knee osteoarthritis with autologous mesenchymal stem cells: Two-year follow-up results, Transplantation, 97, e66, 10.1097/TP.0000000000000167
Hernigou, 2014, Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study, Int Orthop, 38, 1811, 10.1007/s00264-014-2391-1
Mautner, 2015, A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature, PM R, 10.1016/j.pmrj.2015.02.005
Murray, 2018, Reporting standards in clinical studies evaluating bone marrow aspirate concentrate: a systematic review, Arthroscopy, 34, 1366, 10.1016/j.arthro.2017.11.036
Magalon, 2016, DEPA classification: a proposal for standardizing PRP use and a retrospective application of available devices, BMJ Open Sport Exerc Med, 2, 1, 10.1136/bmjsem-2015-000060
Schaer, 2013, Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins, Blood, 121, 1276, 10.1182/blood-2012-11-451229
Klatt, 2018, Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis, J Clin Invest, 128, 3906, 10.1172/JCI92077
Karsten, 2018, Red blood cells: The primary reservoir of macrophage migration inhibitory factor in whole blood, Cytokine, 102, 34, 10.1016/j.cyto.2017.12.005
Mazzucco, 2009, Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure, Vox Sang, 97, 110, 10.1111/j.1423-0410.2009.01188.x
Everts, 2006, Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation, Transfus Med, 16, 363, 10.1111/j.1365-3148.2006.00708.x
Degen, 2017, Commercial separation systems designed for preparation of platelet-rich plasma yield differences in cellular composition, HSS J, 13, 75, 10.1007/s11420-016-9519-3
Giusti, 2009, Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells, Transfusion, 49, 771, 10.1111/j.1537-2995.2008.02033.x
Cavallo, 2014, Comparison of platelet rich plasma formulations for cartilage healing: an in vitro study, J Bone Joint Surg Am, 96, 423, 10.2106/JBJS.M.00726
Dragoo, 2012, Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons, Am J Sports Med, 40, 1274, 10.1177/0363546512442334
DeLong, 2012, Platelet-rich plasma: The PAW classification system, Arthroscopy, 28, 998, 10.1016/j.arthro.2012.04.148
Dohan Ehrenfest, 2014, Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives, Muscles Ligaments Tendons J, 4, 3, 10.32098/mltj.01.2014.02
Muschler, 2001, Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors, J Orthop Res, 19, 117, 10.1016/S0736-0266(00)00010-3
Pontikoglou, 2011, Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation, Stem Cell Rev, 7, 569, 10.1007/s12015-011-9228-8
Chamberlain, 2007, Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing, J. Stem Cell, 2739, 2739, 10.1634/stemcells.2007-0197
Moatsche, 2017, Biological treatment of the knee with platelet-rich plasma or bone marrow aspirate concentrates A review of the current status, Acta Orthop, 88, 670, 10.1080/17453674.2017.1368899
Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143
Fong, 2011, Stem cell homing in musculoskeletal injury, Biomaterials, 32, 395, 10.1016/j.biomaterials.2010.08.101
Imam, 2017, A systematic review of the clinical applications and complications of bone marrow aspirate concentrate in management of bone defects and nonunions, SICOT J
Braun, 2014, The effect of platelet rich plasma formulations and blood products on human synoviocytes: Implications for intra-articular injury and therapy, Am J Sports Med, 42, 1204, 10.1177/0363546514525593
Hooiveld, 2003, Short term exposure of cartilage to blood results in apoptosis, Am J Pathol, 162, 943, 10.1016/S0002-9440(10)63889-8
Tajima, 2017, Hemoglobin stimulates the expression of ADAMTS-5 and ADAMTS-9 by synovial cells: a possible cause of articular cartilage damage after intra-articular hemorrhage, BMC Muskuloskelet Disord, 18, 449, 10.1186/s12891-017-1815-7
Dawson, 2013, Enhancing the osteogenic efficacy of human bone marrow aspirate: concentrating osteoprogenitors using wave-assisted filtration, Cytotherapy, 15, 242, 10.1016/j.jcyt.2012.09.004
Chahla, 2017, A call for standardization in platelet-rich plasma preparation protocols and composition reporting. A systematic review of the clinical orthopaedic literature, J Bone Joint Surg Am, 99, 1769, 10.2106/JBJS.16.01374
Finch, 1982, Erythropoiesis, erythropoietin, and iron, Blood, 60, 1241, 10.1182/blood.V60.6.1241.1241
Mohandas, 2008, Red cell membrane: past, present, and future, Blood, 112, 3939, 10.1182/blood-2008-07-161166
Park, 2010, Measurement of red blood cell mechanics during morphological changes, Proc Natl Acad Sci, 107, 6731, 10.1073/pnas.0909533107
Lang, 2005, Mechanisms of suicidal erythrocyte death, Cell Physiol Biochem, 15, 195, 10.1159/000086406
Ghashghaeinia, 2012, The impact of erythrocyte age on eryptosis, British J Haemat, 157, 606, 10.1111/j.1365-2141.2012.09100.x
Frei, 2008, Vascular dysfunction in a murine model of severe hemolysis, Blood, 112, 398, 10.1182/blood-2007-12-126714
Gozzelino, 2010, Mechanisms of cell protection by heme oxygenase-1, Annu Rev Pharmacol Toxicol, 50, 323, 10.1146/annurev.pharmtox.010909.105600
Jones, 1995, A relationship between Reynolds stresses and viscous dissipation: implications to red cell damage, Ann Biomed Eng, 23, 21, 10.1007/BF02368297
Meyer, 2010, Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function, J Am Coll Cardiol, 55, 454, 10.1016/j.jacc.2009.07.068
Figueiredo, 2007, Characterization of heme as activator of toll-like receptor 4, J Biol Chem, 282, 20221, 10.1074/jbc.M610737200
Kumar, 2005, Free heme toxicity and its detoxification systems in human, Toxicol Lett, 157, 175, 10.1016/j.toxlet.2005.03.004
Vinchi, 2013, Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis, Oxid Med Cell Long, 10.1155/2013/396527
Jeney, 2002, Pro-oxidant and cytotoxic effects of circulating heme, Blood, 100, 879, 10.1182/blood.V100.3.879
Nagy, 2010, Red cells, hemoglobin, heme, iron, and atherogenesis, Arterioscler Thromb Vasc Biol, 30, 1347, 10.1161/ATVBAHA.110.206433
Smith, 2015, Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders, Front Physiol, 10.3389/fphys.2015.00187
Seixas, 2009, Heme oxygenase-1 affords protection against noncerebral forms of severemalaria, Proc Natl Acad Sci USA, 106, 15837, 10.1073/pnas.0903419106
Ogawa, 2001, Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1, EMBO J, 20, 283543, 10.1093/emboj/20.11.2835
Alayash, 2004, Oxygen therapeutics: can we tame haemoglobin?, Nat Rev Drug Discov, 3, 152, 10.1038/nrd1307
Rother, 2005, The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin, JAMA, 293, 1653, 10.1001/jama.293.13.1653
Repsold, 2018, Eryptosis: An erythrocyte’s suicidal type of cell death, BioMed Res Int, 10.1155/2018/9405617
Berg, 2015, Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis, Cell Death Differ, 8, 1197, 10.1038/sj.cdd.4400905
Esmon, 2005, The interactions between inflammation and coagulation, Br. J Haematol, 131, 417, 10.1111/j.1365-2141.2005.05753.x
Betal, 2008, Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin binding domain, Trans Res, 152, 165, 10.1016/j.trsl.2008.07.007
Baugh, 2002, Macrophage migration inhibitory factor, Critical Care Med, 30, S27, 10.1097/00003246-200201001-00004
Lehmann, 2005, Intracellular detection of macrophage migration inhibitory factor in peripheral blood leukocytes, Free Radic Biol Med, 38, 1170, 10.1016/j.freeradbiomed.2004.12.029
Jensen, 2001, Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count, Eur J Haematol, 66, 143, 10.1034/j.1600-0609.2001.00359.x
Calandra, 1995, MIF as a glucocorticoid-induced modulator of cytokine production, Nature, 377, 68, 10.1038/377068a0
Pohl, 2016, MIF reflects tissue damage rather than inflammation in post-cardiac arrest syndrome in a real-life cohort, Resuscitation, 100, 32, 10.1016/j.resuscitation.2015.12.015
Zhang, 2016, Synovial fluid macrophage migration inhibitory factor levels correlate with the severity of self-reported pain in knee osteoarthritis patients, Med Sci Monit, 22, 2182, 10.12659/MSM.895704
Liu, 2012, Association of MIF serum and synovial fluid with severity of knee osteoarthritis, Clin Biochem, 45, 737, 10.1016/j.clinbiochem.2012.03.012
Michiels, 2003, Endothelial cell functions, J Cell Physiol, 196, 430, 10.1002/jcp.10333
Maitz, 2015, Applications of synthetic polymers in clinical medicine, Biosurf Biotribology, 1, 161, 10.1016/j.bsbt.2015.08.002
Nakagawa-Tosa, 1995, Stimulation of haptoglobin synthesis by interleukin-6 and tumor necrosis factor, but not by interleukin-1, in bovine primary cultured hepatocytes, J Vet Med Sci, 57, 219, 10.1292/jvms.57.219
Harrison, 2011, Erythrocytes inhibit ligament fibroblast proliferation in a collagen scaffold, J Orthop Res, 29, 1361, 10.1002/jor.21321
Xiong, 2012, Macrophage migration inhibitory factor inhibits the migration of cartilage end plate-derived stem cells by reacting with CD74, PLoS One, 10.1371/annotation/a5edef40-e46d-4810-9008-dbda429ccc2c
Alves, 2018, A review of platelet-rich plasma: history, biology, mechanisms of action, and classification, Skin Appendage Disord, 4, 18, 10.1159/000477353
Grisendi, 2010, GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion, Cytotherapy, 12, 466, 10.3109/14653241003649510